Symbiomics
Florian├│polis
About Symbiomics
Symbiomics provides the next-generation biologicals based on robust-colonizing microbes for plant growth improvement through sequencing technologies, machine learning, and genome editing tools.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2025)
- Website: symbiomics.com.br
- Phone: [email protected]
Industries & Categories
Agriculture, Biotechnology, Organic
Social Profiles
Canonical: https://fsome.com/organization/symbiomics-83020 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.